The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data. uri icon

Overview

publication date

  • June 2, 2017

Research

keywords

  • Eukaryotic Initiation Factor-4E
  • Lymphoma
  • Ribavirin

Identity

Scopus Document Identifier

  • 85020163604

Digital Object Identifier (DOI)

  • 10.1080/10428194.2017.1323270

PubMed ID

  • 28573908

Additional Document Info

volume

  • 59

issue

  • 1